PD-L1 upregulation had no impact on the ability of T cells to kill MDS tumor cells since the percent lysis did not vary between PD-L1+ or PD-L1- MDS cells at time 0 (Figure 3D) even though T cells expressed PD-1 (Figure 3E). This evidence concerns the gene CD274 and myelodysplastic syndrome.